Family History of Breast Cancer and Breast Cancer Risk between Malays Ethnicity in Malaysia and Indonesia: A Meta-Analysis

  • Ricvan Dana NINDREA Doctoral Program, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia 2. Department of Public Health, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
  • Teguh ARYANDONO Department of Surgery, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Lutfan LAZUARDI Department of Health Policy and Management, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
  • Iwan DWIPRAHASTO Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogya-karta, Indonesia
Keywords: Breast neoplasms, Family history, Malaysia, Indonesia

Abstract

Background: Breast cancer is the most common cancer type in women not only in world but also in Malays ethnicity between Malaysia and Indonesia. Breast cancer has varying incidence in every country, but genetic factor by family history influence the incidence of breast cancer. This systematic review and meta-analysis was performed to determine family history of breast cancer and breast cancer risk between Malays ethnicity in Malaysia and Indonesia. Methods: This meta-analysis was conducted on published research articles on family history of breast cancer and breast cancer risk between Malays ethnicity in Malaysia and Indonesia published between Jan 1999 and Jul 2018 in the online article databases of PubMed, ProQuest and EBSCO. Pooled odds ratios (OR) were calculated with fixed and random-effect models. Publication bias was visually evaluated by using funnel plots and statistically assessed through Egger’s and Begg’s tests. Data were processed using Review Manager 5.3 (RevMan 5.3) and Stata version 14.2 (Stata Corporation). Conclusion: This analysis confirmed the association of family history of breast cancer and breast cancer risk between Malays ethnicity in Malaysia and Indonesia.    

References

1. Torre LA, Bray F, Siegel RL, et al (2015). Global cancer statistics, 2012. CA Cancer J Clin, 65 (2): 87-108.
2. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61 (2): 69-90.
3. Nindrea RD, Aryandono T, Lazuardi L (2017). Breast cancer risk from modifiable and non-modifiable risk factors among women in Southeast Asia: A meta-analysis. Asian Pac J Cancer Prev, 18 (12): 3201-6.
4. Nindrea RD, Harahap WA, Aryandono T, et al (2018). Association of BRCA1 Promoter Methylation with Breast Cancer in Asia: AMeta- Analysis. Asian Pac J Cancer Prev, 19 (4): 885-9.
5. Clemons M, Goss P (2001). Estrogen and the risk of breast cancer. N Engl J Med, 344 (4): 276–85.
6. Pharoah PDP, Day NE, Duffy S, et al (1997). Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer, 71 (5):800–9.
7. Moons KG, Altman DG, Vergouwe Y, et al (2009). Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ, 338: b606.
8. Nindrea RD, Aryandono T, Lazuardi L, et al (2018). Diagnostic Accuracy of Different Machine Learning Algorithms for Breast Cancer Risk Calculation: a Meta-Analysis. Asian Pac J Cancer Prev, 19 (7): 1747-52.
9. Liberati A, Altman DG, Tetzlaff J, et al (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339: b2700.
10. Wells GA, Shea B, O’Connell D, et al (2009). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
11. Prihartono J, Ohno Y, Budiningsih S, et al (1999). Risk factors in the development of breast cancer among Indonesian women. Med J Indones, 8 (2): 84-9.
12. Wakai K, Dilon DS, Ohno Y, et al (2000). Fat intake and breast cancer risk in an area where fat intake is low: a case-control study in Indonesia. Int J Epidemiol, 29 (1): 20-8.
13. Norsa’adah B, Rusli BN, Imran a. K, et al (2005). Risk factors of breast cancer in women in Kelantan, Malaysia. Singapore Med J, 46 (12):698–705.
14. Leong BD, Chuah JA, Kumar VM, et al (2007). Breast cancer in Sabah, Malaysia: a two year prospective study. Asian Pac J Cancer Prev, 8(4):525–9.
15. Razif SM, Sulaiman S, Hanie SS, et al (2011). The contribution of reproductive factors and family history towards premenopausal breast cancer risk in Kuala Lumpur, Malaysia. Med J Malaysia, 66(3):220–6.
16. Sulaiman S, Shahril MR, Shaharudin SH, et al (2011). Fat Intake and Its Relationship with Pre- and Post-menopausal Breast Cancer Risk: a Case-control Study in Malaysia. Asian Pac J Cancer Prev, 12(9):2167–78.
17. Sulaiman S, Shahril MR, Wafa SW, et al (2014). Dietary carbohydrate, fiber and sugar and risk of breast cancer according to menopausal status in Malaysia. Asian Pac J Cancer Prev, 15(14):5959–64.
18. Darjoko ST, Sapardin AN (2017). Hormonal contraception increases risk of breast tumor based on clinical breast examination among adult women. Univ Med, 36 (2): 138-49.
19. Harahap WA, Ramadhan, Khambri D, et al (2017). Outcomes of trastuzumab therapy for 6 and 12 months in Indonesian national health insurance system clients with operable HER2-positive breast cancer. Asian Pac J Cancer Prev, 18 (4): 1151–6.
20. Mujar NMM, Dahlui M, Emran NA, et al (2017). Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. PloS One, 12 (4): e0176394.
21. Duffy SW, Day NE, Tabar L, et al (1997). Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr, (22):93-7.
22. Petrisek A, Campbell S, Laliberte L (2000). Family history of breast cancer. Impact on the disease experience. Cancer Pract, 8(3):135–42.
23. Halbert CH, Kessler L, Wileyto EP, et al (2006). Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med, 43(5):385–8.
24. Russo A, Herd-Smith A, Gestri D, et al (2002). Does family history influence survival in breast cancer cases? Int J Cancer, 99(3): 427–30.
25. Bosviel R, Garcia S, Lavediaux G, et al (2012). BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. Cancer Epidemiol, 36 (3): e177-82.
26. Hsu NC, Huang YF, Yokoyama KK, et al (2013). Methylation of BRCA1 promoter region is associated with unfavorable
prognosis in women with early-stage breast cancer. PLoS One, 8 (2): e56256.
27. Hasan TN, Leena Grace B, Shafi G, et al (2013). Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer. Clin Transl Oncol, 15 (7): 555-62.
28. Saelee P, Chaiwerawattana A, Ogawa K, et al (2014). Clinicopathological significance of BRCA1 promoter hypermethylation in Thai breast cancer patients. Asian Pac J Cancer Prev, 15 (24): 10585-9.
29. Truong PK, Lao TD, Doan TP, et al (2014). BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population. Asian Pac J Cancer Prev, 15 (22): 9607-10.
30. Wiencke JK (2004). Impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer, 4 (1): 79-84.
31. Harahap WA, Sudji IR, Nindrea RD (2018). BRCA1 promoter methylation and clinico-pathological characteristics in Sporadic Breast Cancer patients in Indonesia. Asian Pac J Cancer Prev, 19 (9): 2643-9.
Published
2019-02-01
How to Cite
1.
NINDREA RD, ARYANDONO T, LAZUARDI L, DWIPRAHASTO I. Family History of Breast Cancer and Breast Cancer Risk between Malays Ethnicity in Malaysia and Indonesia: A Meta-Analysis. Iran J Public Health. 48(2):198-205.
Section
Review Article(s)